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Abstract Personalised modelling offers a new and effective approach for the study
in pattern recognition and knowledge discovery, especially for biomedical applica-
tions. The created models are more useful and informative for analysing and evalu-
ating an individual data object for a given problem. Such models are also expected
to achieve a higher degree of accuracy of prediction of outcome or classification
than conventional systems and methodologies. Motivated by the concept of person-
alised medicine and utilising transductive reasoning [34], personalised modelling
was recently proposed as a new method for knowledge discovery in biomedical
applications [13]. Personalised modelling aims to create a unique computational
diagnostic or prognostic model for an individual. Here we introduce an integrated
method for personalised modelling [15, 10] that applies global optimisation of vari-
ables (features) and an appropriate size of neighbourhood to create an accurate per-
sonalised model for an individual. This method creates an integrated computational
system that combines different information processing techniques, applied at dif-
ferent stages of data analysis, e.g. feature selection, classification, discovering the
interaction of genes, outcome prediction, personalised profiling and visualisation,
etc. It allows for adaptation, monitoring and improvement of an individual’s model
and leads to improved accuracy and unique personalised profiling that could be used
for personalised treatment and personalised drug design.
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1 Introduction
Contemporary medical and other data analysis and decision support systems use
predominantly inductive global models for the prediction of a person’s risk, or of
the likely outcome of a disease for an individual [2, 20]. In such models, features
are pre-processed to minimise learning function’s error (usually a classification er-
ror) in a global way to identify the patterns in large databases. Pre-processing is
performed to constrain the features used for training global learning models. In gen-
eral, global modelling is concerned with deriving a global formula (e.g. a linear
regression function, a “black box neural network”, or a support vector machine)
from a large group of data samples. Once an optimal global model is trained, a set
of features (variables) are selected and then applied to the whole problem space (i.e.
all samples in the given dataset). Thus, the assumption is made that the global model
is able to work properly on any new data sample. In clinical research, therapeutic
treatment designed to target a disease is assumed to be suitable for any new patients
anywhere at anytime. However, such global modelling based medical treatment sys-
tems are not always applicable to the individual patients, as the molecular profiling
information is not taken into account. The heterogeneity of diseases (e.g. cancer),
means that there is different disease progress and different responses to the treat-
ment, even when the patients have similar remarkably morphologically tumours in
the same organ.
Statistic reports from the medical research community have shown that the treat-
ment developed by such global modelling methods are only effective for approxi-
mately 70% of people, leaving the rest of patients with no effective treatment[28].
In the cases of aggressive diseases, e.g. cancer, any ineffective treatment of a patient
(e.g. either a patient not being treated, or being incorrectly treated), can be the differ-
ence between life and death. Thus, more effective approaches are required that are
capable of using a patient’s unique information, such as protein, gene or metabolite
profile to design clinical treatment specific to the individual patient.
1.1 Why Personalised Modelling?
In order to develop an understanding of personalised modelling for medical data
analysis and biomedical applications, we must answer the question: why we need
personalised information modelling technologies? For many common conditions a
patient’s health outcome is influenced by the complex interplay of genetic, clinical
and environmental factors [25]. With the advancement of microarray technologies
collecting personalised genetic data on a genome-wide (or genomic) scale has be-
come quicker and cheaper [23, 9]. Such personalised genomic data may include:
DNA sequence data (e.g. Single Nucleotide Polymorphisms (SNPs), gene and pro-
tein expression data. Many world-wide projects have already collected and pub-
lished a vast amount of such personalised data. For example, Genome-wide As-
sociation Scan (GWAS) projects have so far been published for over 100 human
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traits and diseases and many have made data available for thousands of people
(http://www.genome.gov/gwastudies).
The advance of molecular profiling technologies, including microarray mes-
senger ribonucleic acid (mRNA) gene expression data, proteomic profiling, and
metabolomic information make it possible to develop “personalised medicine”
based on new molecular testing and traditional clinical information for treating in-
dividual patient. According to the United States Congress, the definition of person-
alised medicine is given as “the application of genomic and molecular data to better
target the delivery of health care, facilitate the discovery and clinical testing of new
products, and help determine a person’s predisposition to a particular disease or con-
dition” [27]. The personalised medicine is expected to focus on the factors affecting
each individual patient and for helping fight chronic diseases. More importantly, it
could allow the development of medical treatment tailored to an individual’s needs.
Motivated by the concept of personalised medicine and utilising transductive
reasoning [34], personalised modelling was recently proposed as a new method
for knowledge discovery in biomedical applications. For the purpose of developing
medical decision support systems, it would be particularly useful to use the infor-
mation from a data sample related to a particular patient (e.g. blood sample, tissue,
clinical data and/or DNA) and tailor a medical treatment specifically for her/him.
This information can also be potentially useful for developing effective treatments
for another part of the patient population.
In a broader sense, personalised modelling offers a new and effective approach
for the study in pattern recognition and knowledge discovery. The created models
are more useful and informative for analysing and evaluating an individual data
object for a given problem. Such models are also expected to achieve a higher degree
of accuracy of outcome prediction or classification than conventional systems and
methodologies [13]. In fact, being able to accurately predict an individual’s disease
risk or drug response and using such information for personalised treatment is a
major goal of clinical medicine in the 21st century [11].
Personalised modelling has been reported as an efficient solution for clinical de-
cision making systems [32], because its focus is not simply on the global problem
space, but on the individual sample. For a new data vector, the whole (global) space
usually contains much noise information that presents the learning algorithm work-
ing properly on this new data, though the same information might be valuable for
other data samples. With personalised modelling, the noise (or redundant) infor-
mation can be excluded within the local problem space that is only created for the
observed data sample. This characteristic of personalised modelling makes it a more
appropriate method for discovering more precise information specifically for the in-
dividual data sample than conventional models and systems.
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1.2 Inductive vs. Transductive Reasoning
Inductive and transductive inference are two prevalent approaches used in the de-
velopment of the learning models and systems in artificial intelligence. The original
theory of inductive inference was proposed by Solomonoff [29, 30] in early 1960s
and was used for predicting the new data based on observations of a series of given
data. In the context of knowledge discovery, the inductive reasoning approach is
concerned with the construction of a functional model based on the observations,
e.g., predicting the next event (or data) based upon a series of historical events (or
data) [4, 20]. Many of the statistical learning methods, such as, SVM, Multi Layer
Perceptron (MLP) and neural network models have been implemented and tested on
inductive reasoning problems.
Inductive inference approach is widely used in the development of models and
systems for data analysis and pattern discovery in computer science and engineer-
ing. This approach creates the models based upon known historical data vectors
and applicable to the whole problem space. However, the inductive learning and in-
ference approach is only efficient when the whole problem space (global space) is
searched for the solution of a new data vector. Inductive models generally neglect
any information related to the particular new data sample, which raises an issue
about the suitability of a global model for analysing new input data.
In contrast to inductive learning methods, transductive inference introduced by
Vapnik [34] is a method that creates a model to test a specific data vector (a testing
data vector) based on the observation of a specific group of data vectors (training
data). The models and methods created from transductive reasoning focus on a sin-
gle point of the space (the new data vector), rather than on the whole problem space.
Transductive inference systems emphasise the importance of the utilisation of the
additional information related to the new data point, which brings more relevant in-
formation to suit the analysis of the new data. Within the same given problem space,
transductive inference methods may create different models, each of them specific
for testing every new data vector.
Transductive inference systems have been so far applied to a variety of classifica-
tion problems, such as heart disease diagnostics [36], promoter recognition in bioin-
formatics [16], microarray gene expression data classification [35]. Other examples
using transductive reasoning systems include: evaluating the predicting reliability
in regression models [5], providing additional reliability measurement for medical
diagnosis [19], transductive SVM for gene expression data analysis [26] and a trans-
ductive inference based radial basis function (TWRBF) method for medical decision
support system and time series prediction [31]. Most of these experimental results
have shown that transductive inference systems outperform inductive inference sys-
tems, due to the former’s ability to exploit the structural information of unknown
data.
Some more sophisticated transductive inference approaches have been developed
including: Transductive Neural Fuzzy Inference System with Weighted Data Nor-
malization - TWNFI [32] and Transductive RBF Neural Network with Weighted
Data Normalization - TWRBF [31]. These methods create a learning model based
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on the neighbourhood of new data vector, and then use the trained model to calculate
the output.
Transductive inference approach seems to be more appropriate to build learning
models for clinical and medical applications, where the focus is not simply on the
model, but on the individual patient’s condition. Complex problems may require
an individual or a local model that best fits a new data vector, e.g. a patient to be
clinically treated; or a future time moment for a time-series data prediction, rather
than a global model that does not take into account any specific information from
the object data [32].
2 Global, Local and Personalised Modelling Approaches
Global, local and personalised modelling are currently the three main techniques for
modelling and pattern discovery in the machine learning area. These three types of
modelling techniques are derived from inductive and transductive inference and are
the most commonly used learning techniques for building the models and systems
for data analysis and patter recognition [13, 14]. This section will investigate these
three techniques for data analysis and model design.
 Global modelling creates a model from the data that covers the entire problem
space. The model is represented by a single function, e.g. a regression function,
a radial basis function (RBF) , a MLP neural network, SVM, etc.
 Local modelling builds a set of local models from data, where each model repre-
sents a sub-space (e.g. a cluster) of the whole problem space. These models can
be a set of rules or a set of local regressions, etc.
 Personalised modelling uses transductive reasoning to create a specific model
for each single data point (e.g. a data vector, a patient record) within a localised
problem space.
To explain the concepts of global, local and personalised modelling, we hereby
present a comparative study in which each type of model will be applied to a bench-
mark gene expression dataset, namely colon cancer data [1] for cancer classification.
This comparative study applies several popular algorithms for modelling develop-
ment and investigates the performance using three modelling techniques on a gene
expression data. The data used in the comparative experiment originates from Colon
cancer data that consists of 62 samples of colon epithelial cells from colon cancer
patients. 40 samples are collected from tumors and labeled as “diseased”, and 22
samples are labeled as “normal” collected from a healthy part of the colon of the
same patient. Each sample is represented by 2;000 genes selected out of total 6;500
genes based on the confidence in measured expression levels. Since the goal of
this experiment is to demonstrate the difference of classification performance gen-
erated by three modelling techniques, we simply select 15 out of 2,000 genes by a
signal-noise-to-ratio (SNR) method according to their statical scores for the purpose
of reducing computational cost. SNR is a simple statistical algorithm and widely
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adopted to filter features. Let x¯i and y¯i denote the mean values of the ith gene in
the samples in class 1 and class 2 respectively, sxi and syi are the corresponding
standard deviations. Then each feature’s SNR score can be calcualated as follows:
SNR(i) =
jx¯i  y¯ij
sxi+syi
; i= 1;2;    ;m (1)
where m is the number of features in the given dataset. The greater the SNR value,
the more informative the feature. Therefore, the preprocessed subset used in the
experiment presented here constitutes 62 samples. Each sample contains 15 top fea-
tures(genes) selected based on their statistical SNR ranking scores. The subset is
denoted as Dcolon15.
As our interest for this experiment is mainly in the comparison of the classifica-
tion performance obtained from three different modelling techniques, we applied a
simple validation approach (Hold-out method) to the classification on data Dcolon15:
the given data is split into training and testing data with a specified ratio, i.e. 70%
of samples are used for training and the remaining 30% for testing.
2.0.1 Global Modelling
Linear and logistic regression modelling is one of the most popular global mod-
elling techniques. They have been implemented in a variety of global methods for
modelling gene expression data [7], and for modelling gene regulatory networks [6].
Multiple linear regression (MLR) is a global modelling technique that is among
the simplest of all statistical learning algorithms. MLR analysis is a multivariate
statistical technique that examines the linear correlations between a single depen-
dent variable and two or more independent variables. For multiple linear regres-
sion analysis, the independent variable X is described by an m-dimensional vector:
X = fx1;x2;    ;xmg, and a MLR model can be formulated as:
yi = b0+b1xi1+b2xi2+   +bmximei; i= f1;2;    ;ng (2)
where:
 b is an m-dimensional parameter vector called effects or (regression coeffi-
cients);
 e is the “residual” representing the deviations of the observed values y from their
means y, which are normally distributed with mean 0 and variance;
 n is the number of observations.
For the purpose of investigating the global modelling for classification problems,
an MLR based approach is applied to the subset of colon cancer gene expression
data (Dcolon15). A global MLR-based classifier is created from the training data
(70%) analysis, which is given as:
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Y = 0:1997+0:1354X1+0:70507X2+ 0:42572X3 0:19511X4
+0:0943X5 0:6967X6 1:0139X7+0:9246X8
+0:1550X9+0:6190X10+0:1793X11+1:123X12
 0:1615X13 0:4789X14 0:4910X15
(3)
where Y is an MLR model to predict the new input data vector (here is to predict
whether a patient sample is “diseased” or “normal”), and Xi; i= 1;2; : : : ;15 denotes
each variable (feature).
Function 3 constitutes a global model to be used for evaluating the output for
any new data vector in the 15-dimensional space regardless of where it is located.
This global model extracts a ‘big’ picture for the whole problem space, but lacks an
individual profile [13]. It indicates to certain degree the genes’ importance: X6, X8
and X12 show strong correlation to the corresponding output, while X5, X1, X9 are
less important in terms of outcome prediction.
Figure 1 shows the prediction result from the global multi-linear regression
model over colon data with selected 15 genes. The results plotted in Figure 1 (a)
and (b) demonstrate the inconsistent issue in microarray gene expression data anal-
ysis: the accuracy from testing data is significantly lower than that from training
data - 95.3% vs. 73.7%, when the threshold of disease distinction is set to 0:5.
2.1 Local Modelling
Unlike global models, local models are created to evaluate the output function espe-
cially within a sub-space of the entire problem space (e.g. a cluster of data). Multiple
local models can consist of the complete model across the entire problem space. Lo-
cal models are usually based on clustering techniques. A cluster is a group of similar
data samples, where similarity is measured predominantly as Euclidean distance in
an orthogonal problem space. Clustering techniques can be found in the literature:
classical k-means [21], Self-Organising Maps (SOM) [18, 8], fuzzy c-means clus-
tering [3], hierarchical clustering for cancer data analysis [1], a simulated annealing
procedure based clustering algorithm for finding globally optimal solution for gene
expression data [22]. Fuzzy clustering is a popular algorithm used to implement lo-
cal modelling for machine learning problems. The basic idea behind it is that one
sample may belong to several clusters to a certain membership degree, and the sum
of membership degree should be one.
Local learning models adapt to new data and discover local information and
knowledge, that provide a better explanation for individual cases. However, these
local modeling methods do not select specific subsets of features and precise neigh-
bourhood of samples for individual samples that require a personalised modelling in
the medical area. Evolving classification function (ECF) [12, 17] is a representative
technique for local modelling. The classification result from ECF local model over
dataset Dcolon15 is shown in Figure 2(a) and 2(b). The classification accuracy from
ECF model on the training set (70% of the whole data) appeared excellent - 100%
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(a) The classification result using a global MLR model on
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(b) The classification result using a global MLR model on
Dcolon15 testing set (the testing accuracy is 73.7%).
Fig. 1 An example of global modelling: the classification results from a multi-linear regression
model(MLR) over colon cancer gene data, where x axis is the sample index, y axis represents
the value of the actual class label and predicted outcome for each sample. The red square points
represent the actual class labels of the samples, while the black circle points present the predicted
outcome.
accurate, but the classification result from the testing set (30%) is only 78.95% (15
out of 19 samples are correctly classified). It seems that local modelling might not
be an effective approach for analysing this particular gene expression dataset. More-
over, it is difficult to optimise the parameters during the learning process.
2.2 Personalised Modelling
The philosophy behind the proposed personalised modelling is the realisation that
every person is different, and preferably each individual should have their own per-
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(a) A local modelling: the outcomes from ECF model on the
training set of colon cancer data (70%), the training accuracy
is 100%.
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(b) A local modelling: the outcomes from ECF model on the
testing set of colon cancer data (30%), the testing accuracy
is 79.0%.
Fig. 2 An example of local modelling: the experimental results from a local modelling method
(ECF) on the training and testing set from data (Dcolon15), respectively. Black solid line represents
the actual label of the sample, while red dotted line is the predicted outcome.
sonalised models and tailored treatment. In the context of medical research, it has
become possible to utilise individual data for a person with the advance of tech-
nology, e.g., DNA, RNA, protein expression, clinical tests, inheritance, foods and
drugs intake, diseases. Such data is more readily obtainable nowadays, and is easily
measurable and storable in electronic data repositories with less cost.
In contrast to global and local modelling, personalised modelling creates a model
for every new input data vector based on the samples that are closest to the new data
vector in the given dataset. Figure 3 gives an example for personalised problem
spaces. With a transductive approach, each individual data vector that represents a
patient in any given medical area obtains a customised, local model that best fits
the new data. This is contrary to using a global modeling approach where new data
is matched to a model (function) averaged for the entire dataset. A global model
may fail to take into account the specific information particular to individual data
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samples. Moreover, there are no efficient methods for identifying important features
that assist complex disease classification, e.g. which genes, SNPs, proteins and other
clinical information contribute to the disease diagnosis. Hence, a transductive ap-
proach seems to be a step in the right direction when looking to devise personalised
modelling useful for analysing individual data sample, e.g. disease diagnosis, drug
design, etc.
x1
x2
- a new data vector - a sample from D (the Entire problem space)
- a sample from M (can be an existing model)
D1
D2
D
Fig. 3 An example of personalised space, where x1 and x2 represent two new input vectors, D is
the entire (global) problem space, D1 and D2 denote the two personalised spaces for x1 and x2,
respectively.
A personalised modelling framework (PMF) is initially designed for medical data
analysis and knowledge discovery. However, PMF can be extended for solving var-
ious types of data analysis problems that require personalised modelling. PMF can
be briefly described as follows:
1. Apply feature selection on the object data D (the global problem space) to iden-
tify which features are important to a new input vector xv. The selected features
are grouped into a candidate gene pool;
2. Select Kv nearest samples for xv from D to form a local (personalised) problem
space Dpers;
3. Create a personalised model candidate Mx specifically for xv, which includes a
learning function (usually a classifier or a clustering function) denoted by f;
4. Evaluate the candidate feature subset S by a learning function f based on their
performance within the personalised problem space Dpers;
5. Optimising modelMx through an evolving approach until termination conditions
are met. The output is the optimal or near-optimal solution to vector xv. The
solution includes an optimal personalised modelMx and a selected feature subset
S;
6. Use the model Mx to test the new vector xv and calculate the outcome yv;
7. Create a personalised profile for the input vector xv, visualize the outcome with
the selected important features S, and provide an improvement scenario for data
vector xv for a given problem if it is possible.
An outline of PMF is depicted in Figure 4.
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Fig. 4 A PMF for data analysis and knowledge discovery.
KNN method is probably the simplest techniques to use for personalised mod-
elling. In a KNN model, the K nearest samples for every new sample xi are derived
from the given dataset through a distance measurement (usually Euclidean distance),
and the class label for the new sample xi is assigned based on a voting scheme [24].
The classical KNN method calculates the output value yi according to the deter-
mination made by the majority vote of its neighbours, i.e. the new data vector is
assigned to the class most common amongst its k nearest neighbours.
KNN algorithm is one of the most popular algorithms in machine learning, be-
cause it is simple to implement and works fast and effectively on many machine
learning problems. However, the parameter selection is a critical factor impacting
on KNN classifier’s performance, e.g., the choice of value for K. In general, more
nearest neighbours (K) used in KNN method can reduce the effect of noise over
the classification, but would make the boundaries between classes less distinct. If
too few neighbours are selected, there can be insufficient information for decision
making. Also, the performance of the KNN algorithm can be severely degraded by
the presence of noisy features which is a very common issue in biomedical data.
2.2.1 Weighted Nearest Neighbour Algorithms for Personalised Modelling:
WKNN &WWKNN
In a weighted distance KNN algorithm (WKNN) , the output yi is calculated not
only based on the output values (e.g. class label) y j, but is also dependent on the
weight w j measured by the distance between the nearest neighbours and the new
data sample xi:
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yi =
Ki
å
j=1
w j  y j
Ki
å
j=1
w j
(4)
where:
 yi is the predicted output for the new vector xi;
 y j is the class label of each sample in the neighbourhood of xi.
 Ki is the number of K nearest samples to xi;
 w j is the weight value calculated based on the distance from the new input vector
x j to its K nearest neighbours.
The weight w j can be calculated as follows:
w j =
max(d)  (d j min(d))
max(d)
; j = 1;    ;K (5)
where:
 the value of weights w j ranges from min(d)max(d) to 1;
 d = [d1;d2;    ;dK ] denotes the distance vector between the new input data di and
the its K nearest neighbouring samples;
 max(d) and min(d) are the maximum and minimum values for vector d.
The distance vector d is computed as:
d j =
s
m
å
l=1
(xi;l  x j;l)2; j = 1;    ;K (6)
where m is the number of variables (features) representing the new input vector xi
within the problem space; xi;l and x j;l are the lth variable values corresponding to
the data vector xi and x j, respectively.
The output from aWKNN classifier for the new input vector xi is a “personalised
probability” that indicates the probability of vector xi belonging to a given class.
For a two-class classification problem, a WKNN classifier requires a threshold q
to determine the class label of xi, i.e., if the output (personalised probability) is
less than the threshold q , then xi is classified into the group with “small” class label,
otherwise into the group with “big” class label. For example, in a case of a two-class
problem, the output from WKNN model for sample#1 of data Dcolon15 is 0.1444,
so that this testing sample is classified into class 1 (“small” class label) when the
threshold q is set to 0.5.
Weighted distance and weighted variables K-nearest neighbours (WWKNN) is a
personalised modelling algorithm introduced by Kasabov [13]. The main idea be-
hind WWKNN algorithm is: the K nearest neighbour vectors are weighted based on
their distance to the new data vector xi, and also the contribution of each variable is
weighted according to their importance within the local area where the new vector
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belongs [13]. In WWKNN, the assumption is made that the different variables have
different importance to classifying samples into different classes when the variables
are ranked in terms of their discriminative power of class samples over the whole
m-dimensional space. Therefore, it will be more likely that the variables have dif-
ferent ranking scores if the discriminative power of the same variables is measured
for a sub-space (localised space) of the entire problem space. The calculation of Eu-
clidean distance d j between a new vector xi and a neighbour x j is mathematically
formulated by:
d j =
s
K
å
l=1
ci;l(xi;l  x j;l)2; j = 1;    ;K (7)
where: ci;l is the coefficient weighing xl in relation with its neighbourhood of xi,
and K is the number of the nearest neighbours. The coefficient ci;l can be calculated
by a SNR function that ranks variables across all vectors in the neighbourhood set
Dnbr(xi):
ci;l = fci;1;ci;2;    ;ci;Kg
ci;l =
jx¯l class1  x¯l class2j
s class1l +s
class2
l
(8)
where:
 x¯l classi, i= f1;2g: the mean value of the lth feature belonging to class i across
the neighbourhood Dnbr(xi) of x j;
 s classil , i = f1;2g: the standard deviation of lth feature belonging to class i
across the neighbourhood Dnbr(xi) of x j.
Comparing to a conventional KNN algorithm, the contribution of WWKNN lies
in the new distance measurement: all variables are weighted according to their
importance as discriminating factors in the neighbourhood area (personalised sub-
space), which might provide more precise information for classification or predic-
tion of the new data vector.
The experimental results from the classification of Dcolon15 data using WKNN
and WWKNN are illustrated in Figure 5. It shows that WWKNN produced better
predicting result for colon cancer data classification, as the predicted outcome from
WWKNN Both WKNN and WWKNN can create an outcome vector indicating the
testing sample’s probability of being diseased, which provides the important infor-
mation for clinical decision making.
3 A Methodology to Build a Personalised Modelling System
We introduce a methodology for using the proposed PMF to build a personalised
modelling system (PMS) to create the personalised model for each new input data
sample based on its unique information. Given a dataset D pertaining to a bioinfor-
matics problem, D = fxi j;yi; i = 1;    ;n; j = 1;    ;mg, where x is a data sample,
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Fig. 5 The experimental
results computed by two
personalised models -
WKNN and WWKNN on
the colon cancer Dcolon15
testing set (it contains 19
samples). x axis is the
sample index and y axis
shows value of the pre-
dicted outcome. K = 15
and the classification
threshold is 0.5. Both of
the models yielded 84.2%
classification accuracy.
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y is the responding outcome, n is the number of samples, m denotes the number of
features (variables). The proposed method aims to optimise a modelMx suitable for
analysing data, specific to every new input data vector xv, e.g. to calculate yv - the
outcome of xv. Data xv contains a number of features that are related to the same
scenario as the data samples in the global data D.
In order to obtain the optimal or near optimal personalised modelMx specifically
for a new data sample xv, the proposed method aims to find the solutions to the
following objectives:
1. Determine howmany and which features (variables) S are most suitable for build-
ing the modelMx that is able to successfully predict the outcome for the new data
vector xv;
2. Determine the appropriate number Kv for the neighbourhood of xv to form a
personalised problem space Dpers;
3. Identify Kv samples from the global data set D which have the pattern most sim-
ilar to the data xv, and use these Kv samples to form the neighbourhood (a per-
sonalised problem space Dpers);
4. Calculate the importance of selected features S within the personalised problem
space Dpers), based on their contribution to the outcome prediction of the data
vectors in Dpers. Compute a weight vector wv for all selected features S;
5. Create the optimal personalised model Mx with the optimised parameters ob-
tained in Steps 14;
6. Validate the obtained model Mx by calculating the outcome yv for the new data
xv;
7. Profile the new input data xv within its neighbourhood Dpers using the most im-
portant features associated with a desired outcome;
8. If possible, provide the scenarios for improving the outcome for the new data
vector xv, which can be helpful for clinical use.
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This is a method for determining a profile of a subject (new input vector xv) using
an optimal personalised model Mx , and for recommending the possible changes to
the profile in relation to a scenario of interest in order to improve the outcome for
xv. The method comprises the following steps:
 Create a personalised profile for a new data vector xv;
 Compare each important feature of input data vector xv to the average value of
important features of samples having the desired outcome;
 Determine which important features of input vector xv can be altered in order to
improve the outcome.
Principally, the decision of which variables should be changed will be based
on the observation of the weight vector Wx of features (i.e. the contribution of the
features to the classification). The term “personalised profile” used here refers to an
input vector xv and to its predicted outcome and related information, such as the size
of its neighbourhood, its most important features specifically, etc.
Within the scope of PMS, the proposed method for building an optimal model
Mx requires the following functional modules:
 A module for selecting most relevant Vv features (variables) S and ranking their
weighter wx by importance for xv;
 the module for the selection of a number Kv of neighbouring samples of xv and
for the selection of neighbouring samples Dpers;
 A module for creating a prediction model Mx, defined by the a set of parameters
Pv, such as Kv, Vv, Dpers which were derived in the previous modules;
 A module for calculating the final output yv responding to the new data xv
 A module for the creation of personalised profile and the design of scenarios for
potential improvement.
4 An Integrated Optimisation Method for Implementing a PMS
There has been very few implementations for PMSs using the computational intelli-
gence for solving complex biomedical applications. In this section, we introduce an
integrated method that has been recently developed for PMS implementations. The
integrated method for personalised modelling (IMPM) [15] is developed based on
the methodology described in Sec 3. For every new individual sample (new data vec-
tor), all aspects of their personalised model (variables, neighbouring samples, type
of models and model parameters), are combined together to be optimised based on
the accuracy of the outcome achieved within the local neighbourhood of the sample.
Next, a personalised model and personalised profile are derived that use the selected
variables and the neighbouring samples with known outcomes. The sample’s profile
is compared with average profiles of the other outcome classes in the neighbourhood
(e.g. positive outcome, or negative outcome of disease or treatment). The difference
between the points and average profiles based on important variables that may need
to be modified through treatment and can be utilised in personalised drug design.
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Algorithm 1 The algorithm of IMPM
1: Data pre-processing stage:
Include data collection, storage, update, etc.
2: Feature selection:
Identify a subset of features (variables) Vx relevant to the new data sample xv from all features
V ;
3: Local problem space creation:
Select a number Kx of samples from the global dataset D to create a neighbourhood Dx. Dx
consists of a group of similar samples to x with the features from Vx;
4: Evaluate the Vx features within the local neighbourhood Dx in terms of their contribution and
obtaining a weight vectorWx;
5: Training model optimisation:
Optimise a local prognostic/classification model Mx that has a model-parameter set Px, a vari-
able set Vx and local training data set Dx;
6: Testing the new data sample:
Apply the optimised personalised model Mx (Px;Vx;Dx) on the new data sample x and output
the prediction result;
7: Profiling:
Generate a functional profile Fx for the new data sample x using the selected setVx of variables,
along with the average profiles of the samples fromDx that belong to different outcome classes,
e.g. Fi and Fj .
8: Perform a comparative analysis between Fx, Fi and Fj to define what variables from Vx are
the most important for the person x that make him/her very differential from the desired class.
These variables may be used to define a personalised course of treatment, such as personalised
medicine.
4.1 A detailed description of the IMPM
The IMPM consists different functional modules and is summarised in Algorithm 1.
Steps 2-5 is an iterative learning (training) process to optimise the local model Mx.
The optimisation continues until the termination criteria are reached, e.g. the maxi-
mum number of iterations is reached or a desired local accuracy of the model for a
local data set Dx is achieved. The optimisation of the parameters of the personalised
model Vx, Kx and Dx is global and is achieved through multiple runs of cEAP that
has been described in the previous section. The resulting competing personalised
models for x form a population of such models that are evaluated over iterations
(generations) using a fitness criterion - the best accuracy of outcome prognosis for
the local neighbourhood of new testing sample x. All variables and parameters of
the personalised model form to an integrated single ‘chromosome’ (refer to Figure
6) where variable values are optimised together as a global optimisation.
Initially, the assumption is made that all feature (variable) setV have equal abso-
lute and relative importance for a new sample x in relation to predicting its unknown
output y:
wv1 = wv2 =;    ;= wvq = 1 (9)
and
wv1;norm = wv2;norm =;    ;= wvq;norm = 1=q (10)
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Fig. 6 A chromosome used in IMPM for the global optimisation of the parameters (‘genes’): the
variables Vx to be selected; their corresponding weights Wx; number K of nearest neighbours to
xv; the neighbourhood Dx with selected K samples s1   sK ; a local prognostic model Mx (e.g.
classifier); a parameter set Pm for the Mx.
The initial numbers for the variables Vx and Kx may be determined in a variety
of different ways without departing from the scope of the method. For example Vx
and Kx may be initially determined by an assessment of the global dataset in terms
of size and/or distribution of the data. The values of these parameters may be con-
strained according to the available data. For example, Vx min = 3 (minimum three
variables used in a personalised model) and Vx max < Kx (the maximum variables
used in a personalised model should be smaller than the number of samples in the
neighbourhoodDx of x), usuallyVx max < 20. The initial set of variables may include
expert knowledge, i.e. variables which are referenced in the literature as highly cor-
related to the outcome of the problem (disease) in a general sense (over the whole
population). Such variables for example are the BRCA genes in the study for breast
cancer prediction [33]. For an individual patient the BRCA genes may interact with
some other genes, which interaction will be specific for the person or a group of
people and is likely to be discovered through local or/and personalised modelling
only [13].
IMPM has a major advantage over global and local modelling methods, as its
modelling process can start with all relevant variables available for a person, rather
than with a pre-fixed set of variables in a global model. Such global models may be
statistically representative for the whole population, but not necessarily representa-
tive for a single person in terms of optimal model and best profiling and prognosis
for this person.
Selecting the initial number Kx of neighbouring samples and the minimum and
the maximum numbers Kx min and Kx max can also depend on the data available and
on the problem in hand. A general requirement is that Kx min >Vx, and, Kx max < cN,
where c is a ratio, e.g. 0:5, and N is the number of samples in the neighbourhood Dx
of x. Several formulas have been already suggested and experimented [34], e.g.:
 Kx min equals the number of samples that belong to the class with a smaller num-
ber of samples when the data is imbalanced (one class has many more sam-
ples, e.g. 90%, than the another class) and the available data set D is of small or
medium size (e.g., several tens or several hundreds of samples);
 Kx min =
p
N, where N is the total number of samples in the data set D;
At subsequent iterations of the method, the parameters Vx and Kx along with all
other parameters are optimised via an optimisation procedure, usually an evolution-
ary based algorithm, such as cEAP [10] that optimises all or part of parameters form
the ‘chromosome’ in Figure 6.
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The closest Kx neighbouring vectors to x from D are selected to form a new data
set Dx. A local weighted variable distance measure is used to weigh the importance
of each variableVl (l = 1;2;    ;q) to the accuracy of the model outcome calculation
for all data samples in the neighbourhood Dx. For example, the distance between x
and z from Dx is measured as a local weighted variable distance:
dx;z =
s
q
å
l=1
(1 wl;norm)(xl  zl)2
q
(11)
where: wl is the weight assigned to the variable Vl and its normalised value is
calculated as:
wl;norm =
wl
q
å
i=1
wi
(12)
Here the distance between a cluster centre (in our case it is the vector x) and clus-
ter members (data samples from Dx) is calculated not only based on the geometrical
distance, as it is in the traditional nearest neighbour methods, but on the relative
variable importance weight vectorWx in the neighbourhood Dx as suggested in [13].
After a subset Dx of Kx data samples are selected based on the variables from Vx,
the variables are ranked in a descending order of their importance for prediction of
the output y of the input vector x and a weighting vector Wx is obtained. Through
an iterative optimisation procedure the number of the variables Vx to be used for an
optimised personalised model Mx will be reduced, and only the most appropriate
variables that lead to the best local prediction accuracy forMx will be selected. For
weightingWx (i.e. ranking) of the Vx variables, alternative algorithms can be used,
such as t-test, Signal-to-Noise ratio (SNR), etc.
In the SNR algorithm,Wx are calculated as normalised coefficients and the vari-
ables are sorted in descending order:V1;V2;    ;Vv, where:w1>=w2>=   >=wv,
using the Equation 8. This method is very fast, but evaluates the importance of the
variables in the neighbourhood Dx one by one and does not take into account a
possible interaction between the variables, which might affect the model output.
A learning model, usually a classification or prediction model is applied to the
neighbourhood Dx of Kx data samples to derive a personalised model Mx using the
already defined variables Vx, variable weights Wx and a model parameter set Px.
A variety of classification or prediction models can be used here such as: MLR,
SVM, KNN, WKNN, WWKNN [13], TWNFI [32], etc. The outcome produced
by the weighted KNN (WKNN) classifier for the new sample is calculated based
on the weighted outcomes of the individuals in the neighbourhood according to
their distance to the new sample. In the WWKNN model [13] variables are ranked
and weighted according to their importance for separating the samples of differ-
ent classes in the neighbourhood area in addition to the weighting according to the
distance as in WKNN. In the TWNFI model - transductive, weighted neuro-fuzzy
inference system [32], the number of variables in all personalised models is fixed,
but the neighbouring samples used to train the personalised neuro-fuzzy classifica-
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tion model are selected based on the variable weighted distance to the new sample
the same as it is in the WWKNN.
The vector distance d = [d1;d2;    ;dK ] is defined as the distances between the
new input vector x and the nearest samples (x j;y j) for j = 1 to Kx; max(d) and
min(d) are the maximum and minimum values in d respectively. Euclidean distance
d j between vector x and a neighbouring one x j is calculated as:
d j =
s
V
å
l=1
(1 wl)(xl  x jl)2 (13)
where: wl is the coefficient weighing variable xl in the neighbourhood Dx of x (e.g.
wl can be calculated by a SNR algorithm, refer to Eq.??.
When using the TWNFI classification or prediction model [32], the output y for
the input vector x is calculated as follows:
y=
m
å
l=1
nl
d 2l
P
Õ
j=1
al j  exp[ w
2
j (xi j ml j)2
2s2l j
]
m
å
l=1
1
d 2l
P
Õ
j=1
al j  exp[ w
2
j (xi j ml j)2
2s2l j
]
(14)
where:m is the number of the closest clusters to the new input vector x; each cluster l
is defined as a Gaussian function Gl in aVx dimensional space with a mean value ml
as a vector and a standard deviation dl as a vector too; x = (x1;x2;    ;xv); al (also
a vector across all variables V ) is membership degree to which the input vector x
belongs to the cluster Gaussian function Gl ; nl is a parameter of each cluster [32].
A local accuracy (local error Ex), that estimates the personalised accuracy of the
personalised prognosis (classification) for the data set Dx using model Mx is eval-
uated. This error is a local one, calculated in the neighbourhood Dx, rather than a
global accuracy, that is commonly calculated for the whole problem space D. Dif-
ferent methods can be used for calculating the error, such as: absolute error (AE),
root-mean square error (RMSE) and area under the receiving operating characteris-
tic curve (AUC).
We propose another method to calculate local error specific for model optimisa-
tion:
Ex =
Kx
å
j=1
(1 dx j) E j
Kx
(15)
where: dx j is the weighted Euclidean distance between sample x and sample S j
from Dx that takes into account the variable weightsWx (see Eq.11); E j is the error
between what the model Mx calculates for the sample S j from Dx and what its real
output value is.
Based on a weighted distance measured by the above formula, the closer the data
sample S j to x is, the higher its contribution to the error Ex will be. The calculated
personalised modelMx accuracy is then formulated as:
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Ax = 1 Ex (16)
The best accuracy model obtained is stored for the purpose of future improve-
ment and optimisation. The optimisation procedure iteratively returns to all previous
procedures (step2 to step5) to select another set of parameter values for the param-
eter vector (refer to Figure 6) until the termination criteria are reached. The method
also optimises parameters Px of the classification/prediction procedure. The output
value y for the new input vector x is then calculated by the optimal modelMx Next,
a personalised profile Fx for the person can be assessed against possible desired out-
comes for the scenario, and the possible ways to achieve an improved outcome can
be designed, which is a major novelty of this method. The profile Fx for x is formed
as a vector:
Fx = fVx;Wx;Kx;Dx;Mx;Px; tg (17)
where the variable t represents the time of the model Mx creation. At a future time
(t+D t) the person’s input data will change to x (due to changes in variables such
as age, weight, protein expression values, etc.), or the data samples in the data set
D may be updated and new data samples added. A new profile Fx derived at time
(t+D t) may be different from the current one Fx.
The average profile Fi for every class Ci in the data Dx is a vector containing the
average values of each variable of all samples in Dx from class Ci. The importance
of each variable (feature) is indicated by its weighting in the weight vectorWx. The
weighted distance from the person’s profile Fx to the average class profile Fi (for
each class i) is defined as:
D(Fx;Fi) =
v
å
l=1
jVlx Vlij wl (18)
where wl is the weight of the variable Vl calculated for dataset Dx (see Eq.12 ).
Assuming that Fd is the desired profile (e.g. normal outcome), the weighted dis-
tance D(Fx;Fd) will be calculated as an aggregated indication of how much the
person’s profile should change to reach the average desired profile Fd :
D(Fx;Fd) =
v
å
l=1
jVlx Vld j wl (19)
A scenario for a person’s improvement through changes made to variables (fea-
tures) towards the desired average profile Fd can be produced as a vector of required
variable changes, defined as:
DFx;d = DVlx;d j l = 1;    ;v (20)
DVlx;d = jVlx Vld j; with an importance o f wl : (21)
In order to find a smaller number of variables, as global markers that can be
applied to the whole population X , procedures Step2-step7 are repeated for every
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individual x. All variables from the derived sets Vx are then ranked based on their
likelihood to be selected for all samples. The top m variables (most frequently se-
lected for testing individual models) are considered as a set of global markers Vm.
The procedures P2-P5 will be applied again with the use of Vm as initial variable set
(instead of using the whole initial setV of variables). In this case personalised mod-
els and profiles are obtained within a set of variable markers Vm that would make
treatment and drug design more universal across the whole population X .
4.2 An Optimisation Algorithm (cEAP) for PMS
The method IMPM employes a coevolutionary based algorithm for personalised
modelling (cEAP) to optimise related parameters, selecting informative features and
finding appropriated neighbourhood for personalised modelling [10]. Given a gen-
eral objective optimisation problem f (x) to minimize (or maximize), f (x) is subject
to two constraints gi(x) and h j(x). A candidate solution is to minimize the objective
function f (x)where x represents a n-dimensional decision (or optimisation) variable
vector X = fxi j i= 1;    ;ng from the sample spaceW . The two constraints describe
the dependence between decision variables and parameters involved in the problem,
and must be satisfied in order to optimise f (x). The constraints gi(x) and h j(x) are
denoted as inequalities and equalities respectively and mathematically formulated
as:
gi(x) 0 j i= 1; : : : ;n (22)
h j(x) = 0 j j = 1; : : : ; p (23)
The number of degrees of freedom is calculated by n  p. Note the number of equal-
ity constraints must be smaller than the number of decision variables (i.e. p < n).
The overconstrained issue, occurs when p n, because there is no degrees of free-
dom left for optimising objective function.
The algorithm aims to find the optimal solution to an objective function. Given
an objective function f (x): for x 2 W ;W 6= /0, a global minimum of the objective
problem f (x) can be mathematically defined as f  , f (x)> ¥, only if
8x 2W : f (x) f (x) (24)
where x denotes the minimum solution, W is the sample universe of x.
The optimisation algorithm for selecting genes and optimising the parameters
of learning functions (e.g. a classifier threshold q and the number of neighbours
kv) simultaneously. The basic idea underlying cEAP algorithm is to coevolve the
search in multiple search spaces (here is for feature/variable selection and parameter
optimisation).
The objective of IMPM is to build personalised models for data analysis and
knowledge discovery which are able to minimise the prediction accuracy of disease
distinction and create a personalised profile for individual patient. Given a data D=
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Algorithm 2 The optimisation algorithm - cEAP
1: initialize the subindividuals in the subcomponent for feature selection:
generate a probability vector p with l bits, pi = 0:5, where i 2 1;    ; l,
2: generate two subindividuals from the vector p, respectively:
(Ga;Gb) = generate(p);
3: generate a pair of subindividuals Ka, Kb by a probability function fp;
4: generate a pair of subindividuals: qa and qb using a probability function f 0p;
5: recombine the above subindividuals from three subcomponents into two individuals:
a = Ga+Ka+qa;
b = Gb+Kb+qb;
6: evaluate individuals a and b by a fitness function Fc, respectively;
7: compete individual a and b :
winner; loser = compete(a ;b )
8: create new populations in three subcomponents:
(i) use GA to create the new generation for feature selection subcomponent
if Ga(i) 6= Gb(i)
if winner(i) = 1 then pi = pi+ 1m
else pi = pi  1m
(ii) use evolutionary strategy (ES) to create the new generation for K and q in the other sub-
components:
Keep the winner of K and q to form the offsprings K 0a and q
0
a; the other offsprings K
0
b and
q 0b are generated through a mutation performed by probability functions fp and f
0
p.
9: check wether the termination criteria are reached:
if yes, then the winner individual represents the final solution z , including the selected
features G and optimised parameters K and q 
otherwise iterate the process from step 2.
fX ;Yg j X = xi j;Y = yi; i = 1 : : :n; j = 1 : : :m, the objective is therefore defined to
optimise a classifier that involves the selected features and related parameters:
f (s) f (s) (25)
where f is a classification function, and s denotes an independent variables set.
As s can be represented by the data vector X , Y with selected features and related
parameters, Eq.25 is rewritten as follows:
f (X ;Y;z l ) f (X ;Y;zl); jz 2W ; l = f1;2;3g: (26)
where zl denotes the candidate solution from l different subcomponents. The final
solution is obtained when Eq.25 is fulfilled, i.e. z l is taken as the desired solution
to the problem of gene selection and parameter optimisation when the classification
error is less or equal to the value at any other conditions.
For clarity, the pseudo code of the optimisation algorithm cEAP is given in Al-
gorithm 2.
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5 Experiment
We present an experiment using personalised modelling with IMPM for diagnosis
and profiling of cancer. A benchmark colon cancer gene expression dataset is used
[1]. It consists of 62 samples, 40 collected from colon cancer patients and 22 from
control subjects. Each sample is represented by 2000 gene expression variables. The
objective is to create a diagnostic (classification) system that not only provides an
accurate diagnosis, but also profiles the person to help define the best treatment.
An unbiased verification approach for personalised modelling data analysis
should guarantee that generalisation errors occur in either feature selection or clas-
sification procedures as little as possible. To this end, an efficient data sampling
method should be used in the two procedures to maximally decrease the general-
isation error. In other words, the reliability and generalisability of the informative
features should be evaluated on independent testing subsets, and then these features
can be used for classification. The classification also needs to employ verification
methods to estimate the bias error. Such procedure is shown in Figure 7(b). For
comparison, a simple example of biased validation schema is demonstrated in Fig-
ure 7(a).
Dtrn
Selected
genes
Dtsts
Classificatio
n accuracy
Dtrns
Classifier
training
Dtst
Classification
+
Optimal 
Classifier
Gene selection
(a) An example of biased validation scheme;
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(b) The proposed unbiased validation scheme
Fig. 7 The comparison between a biased and an unbiased verification scheme, where Dtrn and
Dtst are the training and testing set, Dtrns and Dtsts are the training and testing set with selected
genes, respectively. In case (a) (biased verification scheme), the testing set is used twice in gene
selection and classifier training procedure, which introduces a bias error from the gene selection
stage into the final classification step. Whereas in case (b) (the unbiased scheme), the testing set is
only used in the final classification(validation) stage, i.e. the testing set is independent all through
gene selection and classifier training procedures.
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5.1 Personalised Modelling with IMPM for Colon Cancer
Diagnosis and Profiling on Gene Expression Data
An example of a personalised model of colon cancer diagnosis and profiling of a
randomly selected person is given in Figure 813 [15]. Figure 8 shows the evo-
lution (GA) process of feature selection specifically for sample#32 from the colon
cancer data through 600 generations. IMPM selects 18 genes (features) out of 2000
genes based the result from the GA optimisation. Figure 9 illustrates the weighted
importance of the selected 18 genes from Figure 8. The weighted importance is cal-
culated by a weighted SNR model (refer to Eq.12 and 1). The larger the importance
value, the more informative the gene is.
Using the proposed IMPM, an optimised personalised model Mx for sample#32
from the colon cancer data is created. This personalised model Mx consists of the
selected 18 informative genes, along with two parameters - classification threshold
(q = 0:40) and the number of neighbouring samples (K = 18), which are optimised
specific for sample#32. Figure 10 shows the data subset Dx with 18 samples (the
neighbourhood with an appropriate size) of sample#32 using top 3 selected genes
(gene 377, 1285 and 1892). These neighbouring samples are:
61, 41, 12, 1, 38, 22, 26, 31, 34, 28, 19, 44, 6, 49, 57, 3, 8, 43.
The predicted outcome computed by the optimised personalised model Mx is 0.51,
which successfully classifies sample#32 into diseased class (class 2) (the classifica-
tion threshold q is optimised to 0:40 as a model parameter).
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Fig. 8 The evolution of feature (variable) selection for sample#32 from the Colon cancer data (600
generations of GA optimisation; the lighter the colour, the higher the probability of the feature to be
selected; each feature is represented as one bit on the horizontal axis; at the beginning all features
are assigned equal probability to selected as 0.5)
Using the IMPM, a profile and a scenario of potential genome improvement for
colon sample#32 was created shown in Figure 11. Desired average profile is the av-
erage gene expression level from healthy samples group and desired improvement
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Fig. 9 The weighted importance of the selected features for sample#32 using weighted SNR based
model (refer to Eq.12 )
value identifies the change of the gene expression level that this patient (sample#32)
should follow in order to recover from the disease. For example, the expression level
of gene 377 of sample#32 is 761.3790, while the average class profile for class 1
(normal class) and class 2 (diseased class) are: 233.8870 (for class 1) and 432.6468
(for class 2). The distance between the gene expression level of gene 377 for sam-
ple#32 and the desired average class 1 profile is 527.4920, i.e. a potential solution
can be given to the colon cancer patient (sample#32) to decrease his/her gene 377
expression level from 761.3790 to 233:8870. The information in the generated pro-
file can be used for designing personalised treatment for cancer patients.
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Fig. 10 Sample#32 (the blue dot) is plotted with its 18 neighbouring samples selected by IMPM
(red triangles - cancer samples and green triangles - control) in the 3D space of the top 3 gene
variables (genes 377, 1285 and 1892) from Fig.9
To find a small number of variables (potential markers) for the whole population
of colon cancer data, we have used the approach as follows: Based on the experi-
ment result for every sample, we selected 20 most frequently used genes as potential
global markers. Table 1 lists these 20 global markers with their biological informa-
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Fig. 11 The profile of sample#32 (blue dots) versus the average local profile of the control (green)
and cancer (red) samples using the 18 selected genes from Fig.9 as derived through the IMPM.
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Fig. 12 The 20 most frequently selected genes using IMPM across all colon cancer data samples,
where x axis represents the index of the gene in the data and y axis is the frequency of the gene as
the marker of the optimised personalised models for which this gene has been selected.
tion. Here we use 20 selected genes as global markers. The number of 20 is based
on the suggestion in Alon’s work [1].
The next objective of our experiment is to investigate whether utilising these 20
potential marker genes can lead to improved colon cancer classification accuracy
and what classification algorithm will perform best in the proposed IMPM. Four
classification algorithms are tested as personalised models in this experiment, in-
cluding WKNN, MLR, SVM and TWNFI. All the classification results from four
classifiers are validated based on leave-one-out cross validation (LOOCV) across
the whole dataset. Figure 13 shows the average accuracy obtained by these four
algorithms with different size (Kx) of neighbourhood. Table 2 summarises the clas-
sification results from the four classification algorithms using 20 selected potential
marker genes. WKNN and a localised SVM yielded improved classification accu-
racy (90:3%) when compared to the global model [1]. However, the TWNFI clas-
sifier obtained the best classification performance (91:9%). Our results suggest that
a small set of marker genes selected by the IMPM could lead to improved cancer
classification accuracy.
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Fig. 13 A comparison of classification results obtained by 4 classification algorithms using 20
potential maker genes from Figure 12 , where x axis represents the size of neighbourhood and y
axis is the average classification accuracy across all samples. The best accuracy is obtained with
the use of the TWNFI classification algorithm (91.90%)
Table 1 The 20 most frequently selected genes (potential marker genes) using the proposed IMPM
across all colon cancer gene data samples (see Figure 12)
Index of
Gene
GenBank Ac-
cession Number
Description of the Gene (from GenBank)
G377 Z50753 H.sapiens mRNA for GCAP-II/uroguanylin precursor
G1058 M80815 H.sapiens a-L-fucosidase gene, exon 7 and 8, and complete cds.
G1423 J02854 Myosin regulatory light chain 2, smooth muscle ISOFORM (HU-
MAN)
G66 T71025 Human (HUMAN)
G493 R87126 Myosin heavy chain, nonuscle (Gallus gallus)
G1042 R36977 P03001 Transcription factor IIIA
G1772 H08393 COLLAGEN ALPHA 2(XI) CHAIN (Homo sapiens)
G765 M76378 Human cysteine-rich protein (CRP) gene, exons 5 and 6.
G399 U30825 Human splicing factor SRp30c mRNA, complete cds.
G1325 T47377 S-100P PROTEIN (HUMAN).
G1870 H55916 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE, MITOCHON-
DRIAL PRECURSOR (HUMAN)
G245 M76378 Human cysteine-rich protein (CRP) gene, exons 5 and 6.
G286 H64489 Leukocyte Antigen CD37 (Homo sapiens)
G419 R44418 Nuclear protein (Epstein-barr virus)
G1060 U09564 Human serine kinase mRNA, complete cds.
G187 T51023 Heat shock protein HSP 90-BETA (HUMAN)
G1924 H64807 Placental folate transporter (Homo sapiens)
G391 D31885 Human mRNA (KIAA0069) for ORF (novel proetin), partial cds.
G1582 X63629 H.sapiens mRNA for p cadherin.
G548 T40645 Human Wiskott-Aldrich syndrome (WAS) mRNA, complete cds.
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Table 2 The best classification accuracy obtained by four classification algorithms on colon cancer
data with 20 potential maker genes. Overall - overall accuracy; Class 1 - class 1 accuracy; Class 2
- class 2 accuracy;
Classifier Overal[%] Class 1[%] Class 2[%] Neighbourhood size
MLR (Personalised) 82.3 90.0 68.2 3
SVM (Personalised) 90.3 95.0 81.8 12
WKNN 90.3 95.0 81.8 6
TWNFI 91.9 95.0 85.4 20
Original publication [1] 87.1 - - -
6 Conclusion and Future Development of Personalised
Modelling System
When compared to global or local modelling, the proposed personalised modelling
method (IMPM) has a major advantage. With personalised modelling methods, the
modelling process starts with all relevant variables available for a person, rather
than with a fixed number of features required by a global model. Such a global
model may be statistically representative for a whole population (global problem
space), but not necessarily representative for a single person in terms of best prog-
nosis for this person. The proposed IMPM leads to a better prognostic accuracy and
a computed personalised profile. With global optimisation, a small set of variables
(potential markers) can be identified from the selected variable set across the whole
population. This information can be utilised for the development of new more ef-
ficient drugs. A scenario for outcome improvement is also created by the IMPM,
which can be utilised for the decision of efficient personalised treatment. We hope
that this paper will motivate the biomedical applications of personalised modelling
research.
Personalised modelling methods and systems are not going to substitute experts
and current global or local modelling methods, but they are expected to derive in-
formation that is specifically relevant to a person and help individuals and clinicians
make better decisions, thus saving lives, improving quality of life, and reducing cost
of treatment. The IMPM method is capable of discovering more useful information,
including selected informative genes and optimal disease classification parameters
specifically for the observed patient sample, which are helpful to construct the clin-
ical decision support systems for cancer diagnosis and prognosis. For biological
reference, some of experimental findings are proofed in the literature, e.g. the se-
lected genes of colon cancer data by our method are reported as biomarkers in other
published papers.
In summary, personalised modelling offers a novel and integrated methodology
that comprises different computational techniques for data analysis and knowledge
discovery. Compared with the results obtained by other published methods, the new
algorithms and methods based on personalised modelling have produced improved
outcomes in terms of prediction accuracy and discovered more useful knowledge,
because they take into account the location of new input sample in a subspace. The
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Fig. 14 A framework structure of the proposed ISPM system
subspace (local space) excludes noise data samples and provides more precise in-
formation for analysing new input data sample.
Personalised modelling is an adaptive and evolving technique, in which new data
sample can be continuously added to the training dataset and subsequently con-
tribute the learning process of personalised modelling. More importantly, the tech-
nique of personalised modelling offers a new tool to give a profile for each new indi-
vidual data sample. Such characteristic makes personalised modelling based meth-
ods are promising for medical decision support systems and personalised medicine
design, especially for complex human disease diagnosis and prognosis, such as can-
cer and brain disease.
However, as a personalised modelling system creates a unique (personalised)
model for each testing data sample, it requires more computational power and per-
formance time than traditional global modelling methods, especially to train the
models on large data sets. The proposed methods have shown the great potential for
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solving the problems that require individual testing. This study is the first step in
this research direction and needs more in-depth understanding in bioinformatics for
validating the experimental findings and knowledge discovery.
The next step for personalised modelling study is to develop a software plat-
form, called Integrated Optimisation System for Personalised Modelling (ISPM)
that utilises the proposed novel personalised modelling methodology for data anal-
ysis and medical decision support system. This platform offers an user-friendly en-
vironment for predicting the outcome of individual samples based on personal data
and historical data of other similar cases, regardless of the type and the number of
the available data and variables. It incorporates a variety of computational intelli-
gent techniques for personalised modelling for solving different types of research
problems. Figure 14 shows a framework structure of the proposed ISPM system.
The main feature of the ISPM system is that it optimises all the factors related to
the given objective in an integrated way, such as the features (variables), the local
problem space, the classification model and its model parameters, with an objective
function - best accuracy of predicted results for every individual input vector (sam-
ple, patient). ISPM includes a cross-platform class library, integrated development
tools and a cross-platform IDE. The system integrates a variety of modelling meth-
ods based on classical statistical algorithms and sophisticated models developed by
KEDRI. The software system is expected to provide not only improved prediction
accuracy, but reliable risk probability for disease diagnosis and prognosis and per-
sonalised profiles that would help define the best actions (e.g., treatment). ISPMwill
be available both as off-line system and as on-line web-based version.
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